Clinical and experimental advances in treatment of visceral leishmaniasis
Antimicrob Agents Chemother
.
2001 Aug;45(8):2185-97.
doi: 10.1128/AAC.45.8.2185-2197.2001.
Author
H W Murray
1
Affiliation
1
Department of Medicine, Weill Medical College of Cornell University, New York, New York 10021, USA. hwmurray@med.cornell.edu
PMID:
11451673
PMCID:
PMC90630
DOI:
10.1128/AAC.45.8.2185-2197.2001
No abstract available
Publication types
Research Support, U.S. Gov't, P.H.S.
Review
MeSH terms
Antiprotozoal Agents / therapeutic use*
Humans
Immunotherapy
Leishmaniasis, Visceral / drug therapy*
Substances
Antiprotozoal Agents
Grants and funding
AI 16393/AI/NIAID NIH HHS/United States